We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Wireless Adapter Automates Tedious Pipetting Tasks

By LabMedica International staff writers
Posted on 22 Jan 2014
An innovative device that automates most pipetting activities improves accuracy and productivity while reducing hands-on time and risk of repetitive stress injury.

The Integra Biosciences (Zizers, Switzerland) VIAFLO ASSIST was designed for use with any of the VIAFLO II line of multichannel pipettes (8-, 12-, and 16-channels). More...


The VIAFLO ASSIST module communicates with the pipette via wireless Bluetooth technology and controls the actions of the pipette. The module's full color screen and touch wheel interface offer quick and comprehensible menu navigation, which enables precision pipetting throughout the volume range of 0.5 to 1,250 microliters in 6-well to 384-well standard or deep-well plates in landscape or portrait format.

One of the many applications simplified by VIAFLO ASSIST is performance of serial dilutions, which can be tedious due to the many mixing steps that are required. The new system carries out serial dilution protocols automatically. The user defines the number of mixing cycles, speed, and mix volume. The system can work in either landscape or portrait orientation. The concentrated sample can be drawn from a reagent reservoir or from the plate itself (e.g., first column). In addition, the sample can also be aspirated with the pipette from an external source before placing it on the VIAFLO ASSIST and starting the protocol.

The VIAFLO ASSIST reduces the need for traditional handheld pipetting to a minimum, relieving lab personnel from activities that may cause repetitive stress injuries.

Related Links:

Integra Biosciences



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.